Dr. Robert Gerstenbluth, MD

Dr. Gerstenbluth practices at Ellis Hospital in Schenectady, New York, part of Ellis Hospital.

Dr. Gerstenbluth's NPI, 1326078387, was assigned on July 4, 2006. Dr. Gerstenbluth holds New York license 232057.

Dr. Gerstenbluth's primary practice is Ellis Hospital, at 1101 Nott Street, Schenectady, NY 12308 in Schenectady County. The practice phone is (518) 243-4196.

Dr. Gerstenbluth's primary practice is Ellis Hospital in Schenectady, New York, part of Ellis Hospital. Dr. Gerstenbluth is also affiliated with Sunnyview Rehabilitation Hospital. The medical group on file is Albany Med EmUrgentCare. Dmand AI also links Dr. Gerstenbluth to 3 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account. Dr. Gerstenbluth's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gerstenbluth practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Gerstenbluth's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Gerstenbluth is licensed in New York.

CMS data shows 919 Medicare services from Dr. Gerstenbluth across 17 procedure codes in 2024, for 479 Medicare patients. Medicare paid $57,829 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 479 Medicare patients who saw Dr. Gerstenbluth in 2024. The largest group is 75 to 84, with 180 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gerstenbluth's median patient age at 74, with 24% women.

In 2024, Dr. Gerstenbluth wrote 2,895 Medicare Part D claims for 786 patients. 91% of them were for generic drugs. CMS names the drug for 2,753 of them, across 29 drugs with 11 or more claims each, at $813,693 in total drug cost. In 2023, CMS named 2,423 claims across 27 drugs.

Dr. Gerstenbluth accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 21 procedures of prostate resection by Dr. Gerstenbluth, more than 83% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 365 general payments to Dr. Gerstenbluth from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Astellas Pharma US Inc paid the most, $1,518.